Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Pepper

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Multiple Sclerosis and Related Disorders|April 17, 2015
MSer - A new, neutral descriptor for someone with multiple sclerosisDavid Baker, George Pepper, Freddie Yauner, et al.
Multiple Sclerosis and Related Disorders|October 10, 2021
Patients' experiences of self-identification, seeking support, and anticipation of potential relapse in multiple sclerosisCharlotte R Wicks, Rob Sloan, Sophie DiMauro, et al.
Multiple Sclerosis and Related Disorders|November 27, 2018
Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: A critical interpretive synthesisIeva Eskyte, Ana Manzano, George Pepper, et al.
Multiple Sclerosis and Related Disorders|September 20, 2016
Brain health: time matters in multiple sclerosisGavin Giovannoni, Helmut Butzkueven, Suhayl Dhib-Jalbut, et al.
Patient Education and Counseling|May 28, 2020
Impact of communication on first treatment decisions in people with relapsing-remitting multiple sclerosisAna Manzano, Ieva Eskytė, Helen L Ford, et al.
The Patient|April 18, 2023
Decision Making About Disease-Modifying Treatments for Relapsing-Remitting Multiple Sclerosis: Stated Preferences and Real-World ChoicesEdward J D Webb, David Meads, Ieva Eskytė, et al.
The Patient|June 27, 2020
The Impact of Reproductive Issues on Preferences of Women with Relapsing Multiple Sclerosis for Disease-Modifying TreatmentsEdward J D Webb, David Meads, Ieva Eskytė, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 10, 2018
Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?Zhifeng Mao, César Álvarez-Gonzalez, Stefania De Trane, et al.
Multiple Sclerosis and Related Disorders|December 15, 2017
Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group, Peter Rieckmann, Diego Centonze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2018
International consensus on quality standards for brain health-focused care in multiple sclerosisJeremy Hobart, Amy Bowen, George Pepper, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Multiple Sclerosis and Related Disorders|April 17, 2015
MSer - A new, neutral descriptor for someone with multiple sclerosisDavid Baker, George Pepper, Freddie Yauner, et al.
Multiple Sclerosis and Related Disorders|October 10, 2021
Patients' experiences of self-identification, seeking support, and anticipation of potential relapse in multiple sclerosisCharlotte R Wicks, Rob Sloan, Sophie DiMauro, et al.
Multiple Sclerosis and Related Disorders|November 27, 2018
Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: A critical interpretive synthesisIeva Eskyte, Ana Manzano, George Pepper, et al.
Multiple Sclerosis and Related Disorders|September 20, 2016
Brain health: time matters in multiple sclerosisGavin Giovannoni, Helmut Butzkueven, Suhayl Dhib-Jalbut, et al.
Patient Education and Counseling|May 28, 2020
Impact of communication on first treatment decisions in people with relapsing-remitting multiple sclerosisAna Manzano, Ieva Eskytė, Helen L Ford, et al.
The Patient|April 18, 2023
Decision Making About Disease-Modifying Treatments for Relapsing-Remitting Multiple Sclerosis: Stated Preferences and Real-World ChoicesEdward J D Webb, David Meads, Ieva Eskytė, et al.
The Patient|June 27, 2020
The Impact of Reproductive Issues on Preferences of Women with Relapsing Multiple Sclerosis for Disease-Modifying TreatmentsEdward J D Webb, David Meads, Ieva Eskytė, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 10, 2018
Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?Zhifeng Mao, César Álvarez-Gonzalez, Stefania De Trane, et al.
Multiple Sclerosis and Related Disorders|December 15, 2017
Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group, Peter Rieckmann, Diego Centonze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2018
International consensus on quality standards for brain health-focused care in multiple sclerosisJeremy Hobart, Amy Bowen, George Pepper, et al.
Pageof 1